Structure/Function Claims and FTC Advertising Risk: What Supplement Insurance Does and Doesn't Cover

Insurance for a supplement FTC advertising claim is mostly a gap your policy quietly leaves open. Standard general liability includes advertising injury coverage, but that grant pays for a short list of offenses that does not include a regulator challenging your structure/function or disease claims. The civil penalties and consumer refunds the FTC or a court collects are fines, and insurers treat fines as uninsurable.

A private customer lawsuit over the same label is a different animal, and even there the coverage is narrow. This post explains what structure/function claims are, what the FTC makes you prove, why advertising injury coverage does not reach false health claims, and the handful of places partial coverage actually lives.

Does supplement insurance cover an FTC advertising claim?

Mostly no. An FTC action over how you advertise a supplement is a government enforcement matter, not a third party suing you for damages. General liability responds to suits seeking damages for a covered injury. The money the FTC pursues arrives as civil penalties, injunctions, and consumer refunds, and penalties are the kind of cost insurers will not fund.

The FTC polices deceptive health advertising under its authority to stop unfair or deceptive acts. When it targets a supplement brand, it can seek an order to halt the claims, penalties, and money back for consumers. Insurance stays out of most of this for one structural reason: covering government fines and penalties is considered contrary to public policy, so standard policies exclude them (per IRMI). Defense costs are the one piece that might be funded somewhere, but not by the advertising injury grant most founders assume covers it.

The gap gets wider once you separate the two things a supplement brand can face. A regulator opening an inquiry is one track, and a customer or class filing a private lawsuit is another. Founders tend to picture the second when they think about "advertising" coverage, but the enforcement track is the one that carries the uninsurable penalties, and it is often the one that arrives first once a claim gets flagged.

What's the line between structure/function and disease claims?

A structure/function claim describes how an ingredient supports the normal structure or function of the body, like "supports healthy digestion." Under the 1994 Dietary Supplement Health and Education Act, you can make one if you can substantiate it, you carry the FDA disclaimer, and you notify the FDA within 30 days of first marketing it. A disease claim, saying the product treats or prevents a disease, is off limits for a supplement.

The disclaimer is fixed wording: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease" (21 CFR 101.93). Cross into disease territory with a line like "lowers blood pressure" or "fights arthritis" and the FDA treats the product as an unapproved drug, usually opening with a warning letter. The FDA defines a disease as damage to an organ or system that stops it working properly, which is why "supports healthy blood pressure" reads very differently from "lowers blood pressure." (That one word swap is where a lot of brands get into trouble.)

Implied disease claims count too, so a product name, a before-and-after photo, or a citation to a study on treating a condition can turn a compliant label into a disease claim on its own. The safest structure/function claims stay general and body-function focused, and they never lean on the specific condition a shopper is hoping to fix. None of this is an insurance question yet, but the line you draw here decides whether the FTC and FDA exposure ever shows up.

What does the FTC require you to prove about a health claim?

The FTC requires "competent and reliable scientific evidence" for any health claim, and for most supplement claims that means well-conducted human studies rather than testimonials or animal data. Its 2022 Health Products Compliance Guidance spells out that randomized, controlled human clinical trials are the proof the agency looks for behind a health claim.

That standard sits higher than most brands assume when they lift language from a supplier's marketing sheet. Ingredient studies funded to sell the ingredient rarely clear the bar, and consumer surveys never do. The guidance also makes clear the evidence has to match the specific claim, so a study on a 500 mg dose does not support a claim built on your 100 mg gummy. When the FTC decides a claim outran its proof, the case is about substantiation, and no liability policy pays a penalty for making an unsupported claim.

Does advertising injury cover false health claims?

No. Advertising injury, the Coverage B part of a general liability policy, covers five specific offenses: libel, slander, invasion of privacy, copyright infringement in your ads, and misappropriation of another company's advertising idea (per IRMI). Telling shoppers your own product does something it cannot is not on that list, and a separate exclusion removes claims that your goods failed to perform as advertised.

A private deceptive advertising lawsuit, where a customer or class sues over your health claims, at least looks like it could fit. In practice carriers deny most of them under that same failure-to-conform exclusion, which is why false-advertising class actions against DTC brands usually land outside general liability. An FTC or FDA action is further out still, because a regulator is not seeking "damages" for an injury in the way the policy defines it. The Prop 65 warning lawsuits that hit the same brands sit in this same uncovered zone.

Is an FDA warning letter covered by insurance?

No standard business policy covers an FDA warning letter. A warning letter is a regulatory notice telling you a claim or label breaks the rules rather than a lawsuit seeking damages, so it never triggers a liability policy. The cost of answering it, pulling the claim, reworking labels, and reformulating your marketing falls on the business.

Warning letters also become public on the FDA's website. That can set off a second wave: marketplace takedowns, retailer questions, and sometimes copycat consumer suits that cite the letter as evidence. None of that downstream cost has a policy waiting for it either. The practical takeaway is that FDA and FTC exposure gets managed before publication, through claim substantiation and legal review, because it cannot be handed to an insurer after the fact.

A warning letter is also not the end of the road, since ignoring one can escalate to a seizure, an injunction, or a referral that carries real financial teeth. That later stage is where a private plaintiff or a state attorney general may join in, and that is the point where the coverage question stops being theoretical. Even then, the regulatory penalties themselves stay outside every standard policy.

Where does partial coverage for advertising claims exist?

Real coverage for advertising and health-claim disputes, when a brand has any, sits in three optional places, and none of them pays an FTC penalty. A management liability policy (D&O) with a regulatory-claims extension can fund defense costs for directors and officers in some investigations. Media or advertising errors-and-omissions coverage answers private advertising suits. Product liability engages only when a product physically injures someone.

In Coverwatch policy reviews, supplement brands are the group most likely to carry advertising injury coverage and assume it answers an FTC claim. The real exposure sits across D&O, media, and product liability, and it lands cleanly on none of them.

The D&O extension usually defends the people but excludes the fines, penalties, and consumer refunds a regulator collects. Media and advertising E&O is built for content disputes, so it can respond to a private deceptive-advertising suit while still excluding regulatory penalties. Product liability insurance only engages if someone is hurt, as in a supplement injury claim, and shares nothing with an advertising case. If a contract manufacturer makes your supplement, sort out ingredient and contract-manufacturer liability separately, since that is a product exposure rather than an advertising one.

Buying all three still leaves the FTC penalty uncovered, which is the honest answer to "what policy handles this." The value of the defense-side coverage is that a real investigation runs up legal bills long before anyone reaches a settlement, and a D&O or media policy that funds counsel keeps a mid-size brand from burning cash on lawyers. Reading the specific extension wording matters here, because a regulatory-claims extension that only covers formal proceedings can leave the early inquiry stage unfunded.

How to reduce your FTC and FDA advertising exposure

Because the biggest costs here cannot be insured after the fact, the real work is keeping the claim from being challenged in the first place. Substantiate every health claim with evidence that matches it, keep the FDA disclaimer on your structure/function claims, file the 30-day notice, and have a regulatory lawyer review copy before it goes live. Then place insurance where it genuinely helps, on the defense side.

For ecommerce brands selling supplements, that means checking whether your advertising injury grant, D&O, and any media coverage actually respond to a claims dispute, then buying the extension that fills the defense gap. Coverwatch reads the advertising-injury grant and its exclusions, then places media or management liability where the gap sits, on a flat fee rather than commission, so the recommendation is not tied to selling a bigger policy. A short review of your supplement insurance program costs far less than discovering the gap inside an FTC letter.